MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24,882 | +94.4% | 170,373 | +207.5% | 0.00% | +100.0% |
Q2 2023 | $12,799 | +12.4% | 55,403 | +17.9% | 0.00% | 0.0% |
Q1 2023 | $11,387 | -29.0% | 47,000 | -14.9% | 0.00% | -33.3% |
Q4 2022 | $16,036 | -99.5% | 55,250 | +18.5% | 0.00% | – |
Q3 2022 | $3,031,000 | -0.1% | 46,621 | +10.0% | 0.00% | – |
Q2 2022 | $3,035,000 | -31.1% | 42,402 | -5.6% | 0.00% | – |
Q1 2022 | $4,405,000 | +7.3% | 44,899 | -7.3% | 0.00% | – |
Q4 2021 | $4,106,000 | -11.0% | 48,453 | -16.2% | 0.00% | – |
Q3 2021 | $4,612,000 | -37.9% | 57,800 | -24.2% | 0.00% | -100.0% |
Q2 2021 | $7,428,000 | -25.8% | 76,255 | -10.9% | 0.00% | 0.0% |
Q1 2021 | $10,006,000 | -47.4% | 85,541 | -50.0% | 0.00% | -50.0% |
Q4 2020 | $19,033,000 | -8.7% | 171,209 | -2.5% | 0.00% | 0.0% |
Q3 2020 | $20,854,000 | +27.9% | 175,645 | +22.0% | 0.00% | 0.0% |
Q2 2020 | $16,305,000 | +422.8% | 143,975 | +208.2% | 0.00% | – |
Q1 2020 | $3,119,000 | -27.8% | 46,718 | -1.5% | 0.00% | -100.0% |
Q4 2019 | $4,320,000 | -64.8% | 47,419 | -66.7% | 0.00% | -50.0% |
Q3 2019 | $12,289,000 | -49.2% | 142,533 | -38.3% | 0.00% | -33.3% |
Q2 2019 | $24,197,000 | -26.1% | 230,870 | -11.7% | 0.00% | -40.0% |
Q1 2019 | $32,760,000 | +11.3% | 261,537 | +0.2% | 0.01% | 0.0% |
Q4 2018 | $29,422,000 | -72.6% | 261,019 | -47.9% | 0.01% | -68.8% |
Q3 2018 | $107,253,000 | -32.5% | 500,877 | -11.8% | 0.02% | -33.3% |
Q2 2018 | $158,900,000 | +631.4% | 568,128 | +205.4% | 0.02% | +700.0% |
Q1 2018 | $21,725,000 | – | 186,019 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |